{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE336nnn/GSE336341/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE336341"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"IGF2BP2 promotes esophageal squamous cell carcinoma progression through the PI3K/AKT signaling pathway","description":"This study investigated the role of IGF2BP2 in esophageal squamous cell carcinoma. Bulk RNA-seq was performed in ECA109 cells stably transfected with negative-control shRNA or IGF2BP2 shRNA to identify transcriptomic changes associated with IGF2BP2 knockdown.","dates":{"publication":"2026/08/05"},"accession":"GSE336341","cross_references":{"GSM":["GSM9833068","GSM9833069","GSM9833066","GSM9833067","GSM9833071","GSM9833070"],"GPL":["29480"],"GSE":["336341"],"taxon":["Homo sapiens"],"PMID":["[42510966]"]}}